AI assistant
Structure Therapeutics Inc. — Director's Dealing 2025
Mar 19, 2025
31940_dirs_2025-03-18_6094df7a-ee9f-4b58-b07c-feb44c23c38e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2025-03-15
Reporting Person: Lin Xichen (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-15 | Ordinary Shares | A | 80829 | — | Acquired | 166536 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-15 | Employee Stock Option (right to buy) | $7.02 | A | 196386 | Acquired | 2035-03-15 | Ordinary Shares (196386) | Direct |
Footnotes
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
F3: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F4: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.